Study guide
6.2 Action Potential Propagation and Synaptic Transmission
NPLEX Part I — Biomedical Sciences Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Pacing, and GEA Strategy
1.1 Overview of NPLEX Part I & NABNE Exam Structure 1.2 Deconstructing Biomedical Clinical Vignettes 1.3 General Exam Areas (GEAs) & Passing Standards
2 Chapter 2: Gross Anatomy & Musculoskeletal System
2.1 Musculoskeletal Anatomy of Upper and Lower Extremities 2.2 Structural Anatomy of Head, Neck, Thorax, and Abdomen 2.3 Pelvic Architecture, Perineal Anatomy, and Articular Structures
3 Chapter 3: Histology & Microscopic Anatomy
3.1 Histology of Epithelial, Connective, and Muscular Tissues 3.2 Microscopic Structure of Gastrointestinal, Renal, and Endocrine Organs 3.3 Microscopic Anatomy of Integument, Lymphoid Tissues, and Respiratory Epithelium
4 Chapter 4: Neuroanatomy & Special Senses
4.1 Cranial Nerves, Nuclei, and Peripheral Distribution 4.2 Spinal Cord Tracts, Brainstem Circuits, and Motor/Sensory Pathways 4.3 Cerebral Cortex, Basal Ganglia, Limbic System, and Autonomic Nervous System 4.4 Neuroanatomy of Vision, Audition, Vestibular Function, and Olfaction/Gustation
5 Chapter 5: Embryology & Developmental Anatomy
5.1 Gametogenesis, Fertilization, Blastulation, and Germ Layer Derivatives 5.2 Organogenesis: Cardiovascular and Respiratory System Development 5.3 Gastrointestinal, Urogenital, and Craniofacial Embryology
6 Chapter 6: Cellular & General Physiology
6.1 Membrane Transport Mechanics, Resting Potentials, and Ion Channels 6.2 Action Potential Propagation and Synaptic Transmission 6.3 Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle
7 Chapter 7: Cardiovascular & Respiratory Physiology
7.1 Cardiac Electrophysiology, ECG, and Mechanical Cardiac Cycle 7.2 Hemodynamics, Peripheral Resistance, and Blood Pressure Control 7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics 7.4 Transport of Oxygen/CO2 and Neural/Chemical Control of Breathing
8 Chapter 8: Renal, Fluid, & Acid-Base Physiology
8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics 8.2 Countercurrent Multiplication, Osmoregulation, and Urine Concentration 8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics 8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms
9 Chapter 9: Gastrointestinal, Endocrine, & Reproductive Physiology
9.1 GI Motility, Secretory Functions, Digestion, and Nutrient Absorption 9.2 Hypothalamic-Pituitary Axes, Adrenal Gland, and Thyroid Physiology 9.3 Endocrine Pancreas, Glucose Regulation, Calcium/Phosphate Homeostasis 9.4 Male and Female Reproductive Endocrinology and Menstrual Cycle Regulation
10 Chapter 10: Enzymology, Bioenergetics, & Carbohydrate/Lipid Metabolism
10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors 10.2 Glycolysis, Pyruvate Dehydrogenase, TCA Cycle, and Oxidative Phosphorylation 10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway 10.4 Fatty Acid Synthesis, Beta-Oxidation, Ketogenesis, and Lipoprotein Transport
11 Chapter 11: Amino Acid/Nucleotide Metabolism & Clinical Genetics
11.1 Amino Acid Degradation, Transamination, and Urea Cycle Disorders 11.2 Purine and Pyrimidine Synthesis, Salvage, and Gout Pathophysiology 11.3 Mendelian Inheritance, Chromosomal Abnormalities, and Molecular Genetics
12 Chapter 12: Immunology & Immunopathology
12.1 Innate Immune Barriers, Phagocytosis, Cellular Pattern Recognition, and Complement System 12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies 12.3 Types I-IV Hypersensitivity Reactions and Mechanisms of Autoimmunity 12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types
13 Chapter 13: Medical Microbiology
13.1 Medical Bacteriology: Gram-Positive, Gram-Negative, and Atypical Bacteria 13.2 Medical Virology: DNA, RNA, Retroviruses, and Viral Pathogenesis 13.3 Medical Mycology: Cutaneous, Systemic, and Opportunistic Fungal Infections 13.4 Medical Parasitology: Protozoan and Helminthic Pathogens
14 Chapter 14: General Pathology & Neoplasia
14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis 14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing 14.3 Neoplasia: Benign vs Malignant Features, Carcinogenesis, Oncogenes, and Tumor Suppressors
15 Chapter 15: Systems Pathology & Disease Mechanisms
15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias 15.2 Glomerulonephritis, Inflammatory Bowel Disease, and Hepatorenal Disease Pathophysiology 15.3 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles 15.4 Hematopoietic System Pathology: Anemias, Coagulopathies, and Hematologic Neoplasms 15.5 Immunological System Pathology: Autoimmune, Amyloid, and Systemic Immune-Mediated Disease 15.6 Integumentary System Pathology: Inflammatory Dermatoses, Blistering Disorders, and Skin Neoplasms 15.7 Musculoskeletal System Pathology: Metabolic Bone Disease, Arthropathies, and Bone Neoplasms 15.8 Reproductive System Pathology: Endocrine, Inflammatory, and Neoplastic Disorders of the Reproductive Tract
6.2 Action Potential Propagation and Synaptic Transmission
Key Takeaways Explain This Topic AI
Action potentials progress through stereotypic voltage-gated ion channel conductance changes: threshold depolarization triggers fast Na_v activation, peak depolarization causes Na_v inactivation and delayed K_v opening, followed by repolarization and after-hyperpolarization.
The absolute refractory period is enforced by Na+ channel inactivation gates (h-gates), establishing an upper ceiling on firing frequency and dictating unidirectional action potential propagation.
Axonal conduction velocity is enhanced by larger axon diameter (reduced internal resistance) and myelination (increased membrane resistance and decreased capacitance), enabling saltatory conduction at Nodes of Ranvier.
Presynaptic neurotransmitter exocytosis requires Ca2+ influx through voltage-gated channels to trigger synaptotagmin binding and SNARE complex fusion, which is targeted and cleaved by neurotoxins like botulinum and tetanus.
Synaptic responses depend on postsynaptic receptor architecture, divided into rapid ionotropic channels (EPSPs/IPSPs) and modulatory metabotropic GPCRs, with neurotransmitter activity terminated via enzymatic cleavage or presynaptic/astrocytic reuptake.
Last updated: July 2026
- 6.2 Action Potential Kinetics and Synaptic Transmission Dynamics
- Ionic Basis of the Action Potential Waveform
An action potential is a rapid, transient, all-or-none electrical reversal of membrane potential across excitable membranes (neurons and muscle cells). The waveform is produced by sequential opening and closing of voltage-gated ion channels.
Resting State (-70 mV) : Membrane potential maintained primarily by background K + K^+ K + leak channels and the N a + / K + Na^+/K^+ N a + / K + ATPase. Voltage-gated N a + Na^+ N a + channels ( N a v Na_v N a v ) have their activation gates ( m m m -gates) closed and inactivation gates ( h h h -gates) open. Voltage-gated K + K^+ K + channels ( K v K_v K v ) have their activation gates ( n n n -gates) closed.
Depolarization Threshold (-55 mV) : Local graded depolarizing stimuli (e.g., EPSPs) bring V m V_m V m to the critical firing threshold (-55 mV). This threshold voltage triggers rapid opening of N a v Na_v N a v activation ( m m m ) gates.
Rapid Depolarization Phase : N a + Na^+ N a + influx surges down its steep electrochemical gradient ( E N a ≈ + 65 mV E_{Na} \approx +65\text{ mV} E N a ≈ + 65 mV ). This induces a regenerative positive feedback cycle ( Hodgkin cycle ): N a + Na^+ N a + influx causes further depolarization, which opens adjacent N a v Na_v N a v channels. Membrane potential shoots rapidly upward toward + 30 mV +30\text{ mV} + 30 mV .
Peak and Overshoot (+30 mV) : Two critical channel gating events occur simultaneously at peak potential:
Time-dependent closure of N a v Na_v N a v inactivation ( h h h ) gates , halting further N a + Na^+ N a + influx.
Delayed opening of voltage-gated K + K^+ K + channel activation ( n n n ) gates (delayed rectifier K v K_v K v channels).
Repolarization Phase : N a + Na^+ N a + conductance drops to zero while K + K^+ K + efflux surges down its electrochemical gradient ( E K ≈ − 90 mV E_K \approx -90\text{ mV} E K ≈ − 90 mV ), rapidly driving V m V_m V m back toward negative values.
After-Hyperpolarization (Undershoot Phase) : K v K_v K v channels close slowly. The sustained high K + K^+ K + conductance causes V m V_m V m to transiently hyperpolarize beyond resting potential, approaching E K + E_{K^+} E K + (around − 85 to − 90 mV -85\text{ to } -90\text{ mV} − 85 to − 90 mV ). As K v K_v K v channels complete closure, background leak channels restore V m V_m V m to the resting level of − 70 mV -70\text{ mV} − 70 mV .
Refractory Periods: Absolute vs. Relative
Refractory periods restrict action potential frequency and enforce unidirectional propagation along axonal membranes.
Absolute Refractory Period (ARP)
Timeframe : Spans from threshold onset through the majority of repolarization.
Molecular Mechanism : Voltage-gated N a + Na^+ N a + channels are either already open or closed in an inactivated state ( h h h -gate closed). A channel with a closed h h h -gate cannot be opened by any stimulus, regardless of intensity.
Physiological Significance : Ensures an action potential cannot re-excite recently depolarized membrane, forcing propagation forward (unidirectional) away from the soma toward the axon terminal. Sets the theoretical upper limit on neuronal firing frequency ( ∼ 1000 Hz \sim 1000\text{ Hz} ∼ 1000 Hz ).
Relative Refractory Period (RRP)
Timeframe : Follows the ARP, spanning late repolarization through the after-hyperpolarization phase.
Molecular Mechanism : A portion of N a v Na_v N a v channels have reset (activation gate closed, inactivation gate reopened), but K v K_v K v channels remain open, producing elevated K + K^+ K + conductance and membrane hyperpolarization.
Requirement : A suprathreshold (larger than normal) depolarizing stimulus is required to recruit sufficient reset N a v Na_v N a v channels and overcome outward K + K^+ K + efflux to reach firing threshold.
Biomechanics of Axonal Conduction Velocity
Conduction velocity ( v v v ) determines the transmission speed of signals along an axon and depends directly on core physical cable properties:
Axon Diameter : Increasing axon diameter increases cross-sectional area, which dramatically reduces internal axial resistance ( R i R_i R i ). Lower R i R_i R i allows depolarizing local current to flow faster and farther down the axon interior. In unmyelinated axons, conduction velocity scales with the square root of diameter ( v ∝ diameter v \propto \sqrt{\text{diameter}} v ∝ diameter ).
Myelination : Formed by Schwann cells in the Peripheral Nervous System (PNS) and Oligodendrocytes in the Central Nervous System (CNS).
Myelin sheaths wrap tightly around axolemma, acting as electrical insulators that dramatically increase membrane resistance ( R m R_m R m , reducing current leakage) and decrease membrane capacitance ( C m C_m C m , reducing charge stored across lipid bilayer).
Nodes of Ranvier and Saltatory Conduction :
Nodes of Ranvier are unmyelinated gaps ( 1 − 2 μ m 1-2\text{ }\mu\text{m} 1 − 2 μ m ) situated between myelinated internodes, densely packed with voltage-gated N a + Na^+ N a + channels ( N a v 1.6 Na_v 1.6 N a v 1.6 ).
Action potentials jump from node to node ( saltatory conduction ), bypassing insulated internodes.
Benefits: Increases conduction velocity up to 120 m/s 120\text{ m/s} 120 m/s (in large A- α \alpha α sensory/motor nerve fibers) while conserving ATP, as N a + / K + Na^+/K^+ N a + / K + ATPase activity is confined primarily to nodal regions rather than the entire axolemma.
Presynaptic Vesicular Exocytosis and Neurotoxins
Chemical synaptic transmission converts an electrical presynaptic action potential into a chemical signal across the synaptic cleft:
Presynaptic Depolarization : An action potential invading the presynaptic axon terminal depolarizes the terminal membrane.
C a 2 + Ca^{2+} C a 2 + Influx : Depolarization opens voltage-gated C a 2 + Ca^{2+} C a 2 + channels (N-type and P/Q-type). C a 2 + Ca^{2+} C a 2 + surges down its steep 10 , 000 10,000 10 , 000 -fold electrochemical gradient into presynaptic active zones.
Calcium Sensor Activation : Incoming C a 2 + Ca^{2+} C a 2 + binds synaptotagmin , a specialized vesicular transmembrane calcium-sensing protein.
SNARE Complex Assembly and Fusion : C a 2 + Ca^{2+} C a 2 + -activated synaptotagmin triggers conformational zippering of the SNARE complex :
v-SNARE : Synaptobrevin (VAMP) located on the synaptic vesicle membrane.
t-SNAREs : Syntaxin-1 and SNAP-25 located on the presynaptic plasma membrane.
The SNARE complex pulls the vesicle into intimate contact with the plasma membrane, opening a fusion pore to release neurotransmitters into the 20 − 40 nm 20-40\text{ nm} 20 − 40 nm synaptic cleft via exocytosis.
Clinical Neurotoxin Targets
Botulinum Toxin ( Clostridium botulinum ): Endopeptidase light chain cleaves SNAP-25 or synaptobrevin at cholinergic neuromuscular junctions, blocking acetylcholine release → \rightarrow → flaccid paralysis .
Tetanus Toxin ( Clostridium tetani ): Taken up at motor endplates, undergoes retrograde axonal transport to spinal inhibitory interneurons (Renshaw cells), where it cleaves synaptobrevin, blocking release of GABA and glycine → \rightarrow → disinhibition of motor neurons → \rightarrow → spastic paralysis (lockjaw, risus sardonicus).
Postsynaptic Receptors and Neurotransmitter Dynamics
Postsynaptic responses are governed by two distinct receptor classes:
Ionotropic Receptors (Ligand-Gated Ion Channels) : Direct, rapid transmission (millisecond kinetics).
Excitatory Postsynaptic Potentials (EPSPs) : Cation-permeable channels ( N a + , C a 2 + Na^+, Ca^{2+} N a + , C a 2 + influx) depolarize the postsynaptic membrane (e.g., Nicotinic Acetylcholine Receptors [nAChR] , AMPA and NMDA Glutamate Receptors ).
Inhibitory Postsynaptic Potentials (IPSPs) : Anion-permeable channels ( C l − Cl^- C l − influx) hyperpolarize the postsynaptic membrane (e.g., G A B A A GABA_A G A B A A Receptors , Glycine Receptors ).
Metabotropic Receptors (G-Protein Coupled Receptors - GPCRs) : Indirect, modulatory transmission (seconds to minutes) operating via second messenger cascades ( c A M P , I P 3 / D A G cAMP, IP_3/DAG c A MP , I P 3 / D A G ). Examples include Muscarinic Acetylcholine Receptors ( M 1 − M 5 M_1-M_5 M 1 − M 5 ) , Adrenergic Receptors ( α 1 , α 2 , β 1 , β 2 \alpha_1, \alpha_2, \beta_1, \beta_2 α 1 , α 2 , β 1 , β 2 ) , Metabotropic Glutamate (mGluR) , and G A B A B GABA_B G A B A B Receptors ( G i G_i G i -coupled, opens K + K^+ K + channels).
Major Neurotransmitter Systems and Termination Pathways
Acetylcholine (ACh) : Primary neurotransmitter at NMJ, parasympathetic postganglionic, and sympathetic preganglionic neurons. Synthesized by Choline Acetyltransferase (ChAT). Cleared rapidly in synaptic cleft by Acetylcholinesterase (AChE) into choline and acetate.
Glutamate : Principal excitatory neurotransmitter in the CNS. Cleared from the synaptic cleft by Excitatory Amino Acid Transporters (EAAT) into surrounding astrocytes, converted to glutamine by glutamine synthetase, and recycled back to neurons.
GABA ( γ \gamma γ -aminobutyric acid) and Glycine : Principal inhibitory neurotransmitters in brain (GABA) and spinal cord (Glycine). GABA is synthesized from glutamate by Glutamate Decarboxylase (GAD) (requiring Pyridoxal phosphate / Vitamin B 6 B_6 B 6 cofactor). Cleared by GAT transporters and degraded by GABA transaminase.
Monoamines (Dopamine, Norepinephrine, Serotonin) : Catecholamines (dopamine, norepinephrine, epinephrine derived from tyrosine) and serotonin (5-HT derived from tryptophan) are cleared primarily via presynaptic reuptake transporters ( DAT, NET, SERT ) and degraded intracellularly by Monoamine Oxidase (MAO) and Catechol-O-methyltransferase (COMT) .
Neurotransmitter Primary Location Receptor Types Mechanism of Action Termination / Inactivation
Acetylcholine NMJ, ANS, CNS nAChR (Ionotropic), mAChR (Metabotropic) Excitatory (nAChR, M1/3/5), Inhibitory (M2) Enzymatic degradation by Acetylcholinesterase (AChE)
Glutamate CNS (Cortex, Hippocampus) AMPA, NMDA, Kainate (Ionotropic), mGluR Primary excitatory signal in CNS ( N a + / C a 2 + Na^+/Ca^{2+} N a + / C a 2 + influx) Reuptake by Astrocytic EAATs → \rightarrow → Glutamine cycle
GABA CNS (Brain) G A B A A GABA_A G A B A A (Ionotropic C l − Cl^- C l − ), G A B A B GABA_B G A B A B (Metabotropic K + K^+ K + ) Primary inhibitory signal in brain ( C l − Cl^- C l − influx / K + K^+ K + efflux) Reuptake via GAT-1 → \rightarrow → GABA Transaminase
Norepinephrine Sympathetic ANS, Locus Coeruleus α 1 , α 2 , β 1 , β 2 , β 3 \alpha_1, \alpha_2, \beta_1, \beta_2, \beta_3 α 1 , α 2 , β 1 , β 2 , β 3 (Metabotropic GPCRs) Sympathetic fight-or-flight, arousal, alertness Presynaptic reuptake (NET), degraded by MAO & COMT
Serotonin (5-HT) Raphe Nuclei, GI tract 5 − H T 1 − 7 5-HT_{1-7} 5 − H T 1 − 7 (Metabotropic except 5 − H T 3 5-HT_3 5 − H T 3 Ionotropic) Mood, sleep, appetite, pain modulation Presynaptic reuptake (SERT), degraded by MAO-A